Identification of Novel Short Peptide Inhibitors of Soluble 37/48 kDa Oligomers of Amyloid β42
Authors:
- Takayasu KawasakiTKTakayasu Kawasaki
- Kenji OnoderaKOKenji Onodera
- Shunsuke KamijoSKShunsuke Kamijo
- 23 August 2011
- journal article
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 75 (8) , 1496-1501
Abstract
Since the soluble oligomers of 42-residue amyloid β (Aβ42) might be neurotoxins at an early stage of Alzheimer's disease (AD), inhibition of soluble Aβ42 oligomerization should be effective in the treatment of AD. We have found by phage display that a 7-residue peptide, SRPGLRR, exhibited inhibitory activity against soluble 37/48 kDa oligomers of Aβ42. In the present study, we newly prepared 3- and 4-residue random peptides libraries and performed pannings of them against soluble Aβ42 to search for important factors in the inhibition of Aβ42 oligomerization. After the fifth round, arginine-containing peptides were enriched in both libraries. SDS-PAGE and size-exclusion chromatography indicated that the inhibitory activities of 4-residue peptides against the soluble 37/48 kDa oligomers of Aβ42 were higher than those of the 3-residue peptides, and RFRK exhibited strong inhibitory activity as well as SRPGLRR. These short peptides should be useful for the suppression of soluble Aβ42 oligomer formation.Keywords
This publication has 22 references indexed in Scilit:
- Selection of Peptide Inhibitors of Soluble Aβ1-42Oligomer Formation by Phage DisplayBioscience, Biotechnology, and Biochemistry, 2010
- Computational selection of inhibitors of Aβ aggregation and neuronal toxicityBioorganic & Medicinal Chemistry, 2009
- Structural Characterization of a Soluble Amyloid β-Peptide OligomerBiochemistry, 2009
- Structural Classification of Toxic Amyloid OligomersJournal of Biological Chemistry, 2008
- Aβ Oligomers – a decade of discoveryJournal of Neurochemistry, 2007
- RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memoryNature, 2006
- Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's diseaseJournal of Neurochemistry, 2005
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature Cell Biology, 2004
- Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrusBrain Research, 2002
- Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxinsProceedings of the National Academy of Sciences, 1998